Hospital
Westchester-Ellenville Hospital, INC.
Westchester-Ellenville Hospital, INC. was paid $11.13M by Medicaid between Jul 2018 and Dec 2024, across 76 billing codes. Its largest line is 99283, emergency room visit (moderate) — 44% of everything it billed.
33Billing provider infoWESTCHESTER-ELLENVILLE HOSPITAL, INC.
ELLENVILLE, NY 12428
ELLENVILLE, NY 12428
33aNPI1073525341assigned 08/13/2006
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$11.13M
24GClaims86,601
24DCodes billed76
24AFirst – last monthJul 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21 | $1K | |
| 2019 | 6,709 | $383K | |
| 2020 | 12,211 | $832K | |
| 2021 | 17,632 | $1.25M | |
| 2022 | 19,238 | $3.89M | |
| 2023 | 20,108 | $3.44M | |
| 2024incomplete | 10,682 | $1.33M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 44% | 14,237 | 13,350 | $4.85M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 6,676 | 6,236 | $1.89M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 16% | 4,552 | 4,425 | $1.73M |
| 80053 | Comprehensive metabolic panel | 5.9% | 6,272 | 5,576 | $656K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.7% | 8,393 | 2,399 | $407K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.6% | 1,260 | 1,199 | $291K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.9% | 2,164 | 2,032 | $215K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.6% | 946 | 924 | $173K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.5% | 684 | 672 | $165K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 504 | 494 | $88K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 433 | 316 | $85K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,164 | 410 | $83K |
64 more codes
| 97164 | <1% | 615 | $72K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,925 | $55K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 217 | $54K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,046 | $39K |
| 97162 | <1% | 231 | $38K | |
| 97010 | <1% | 3,225 | $36K | |
| 12011 | <1% | 104 | $29K | |
| 20610 | <1% | 84 | $27K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 235 | $26K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 377 | $21K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,462 | $13K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 67 | $10K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,054 | $10K |
| 97161 | <1% | 111 | $10K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,462 | $8K |
| 90715 | <1% | 80 | $7K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 156 | $7K |
| 83880 | <1% | 79 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 736 | $4K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 15 | $3K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 787 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 12 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,324 | $2K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 345 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,573 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,161 | $1K |
| 73610 | <1% | 176 | $1K | |
| 73630 | <1% | 203 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,285 | $1K |
| 81001 | <1% | 1,350 | $868.75 | |
| 97014 | <1% | 35 | $581.40 | |
| 73562 | <1% | 127 | $564.01 | |
| 97116 | <1% | 38 | $544.75 | |
| 76830 | Ultrasound, transvaginal | <1% | 15 | $537.30 |
| 87430 | <1% | 733 | $505.74 | |
| 84484 | <1% | 1,006 | $465.22 | |
| 87400 | <1% | 617 | $418.02 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 25 | $380.76 |
| 73130 | <1% | 73 | $330.28 | |
| 93041 | <1% | 936 | $305.49 | |
| 86769 | <1% | 17 | $294.91 | |
| 83690 | <1% | 963 | $261.14 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 78 | $138.87 |
| 73030 | <1% | 31 | $108.55 | |
| 72100 | <1% | 13 | $104.69 | |
| 84703 | <1% | 1,345 | $84.34 | |
| 83735 | <1% | 406 | $65.51 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,855 | $61.26 |
| 73110 | <1% | 15 | $57.51 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 914 | $39.19 |
| 87070 | <1% | 191 | $36.47 | |
| 83605 | <1% | 13 | $25.65 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 178 | $24.07 |
| 81003 | <1% | 332 | $24.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 715 | $20.08 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 577 | $19.51 |
| 87807 | <1% | 32 | $10.48 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 58 | $8.07 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 29 | $2.37 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 308 | $2.18 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 37 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 29 | $0.00 |
| 85730 | 0% | 24 | $0.00 | |
| 85610 | 0% | 54 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKELLEY, STEVEN (PRESIDENT & CEO)